Syncope-Asystole Latency Time in Tilt Table Test: The SALT-TILT Study

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAzienda Ospedaliera di Bolzano

About this trial

Syncope is a common presenting condition. Pacemaker implantation can significantly reduce syncope recurrences in reflex syncope. However, despite careful selection, a substantial proportion of patients treated with pacemakers suffer recurrences of syncope. It is thought that a pronounced vasodepressor component may hinder the efficacy of pacing in patients, preventing adequate cerebral perfusion during the reflex, thus relativizing the anti-bradycardia function of the pacemaker to prevent syncope. It is hypothesised that the time elapsed from the actual loss of consciousness to the asystole recorded on the ECG during Tilt Table Test may be predictive in terms of response to pacemaker therapy, so this parameter becomes the subject of the present study.

Eligibility criteria

Qualifiers

Patients eligible for invasive treatment according to the ESC Guidelines for pacing 2021

Written informed consent

Disqualifiers

Other condition which explains syncope cause other than reflex syncope

Structural heart disease (valvular, ischaemic, cardiomyopathies)

Pregnancy

Patient denial to be recorded on video during tilt table test

Trial design

Treatments tested in this trial

  • Tilt Table Test

Treatment groups

64 Participants
are divided into 1 treatment group

Sponsors and collaborators